| Filed On | Filing |
|---|---|
| 27 Dec 2022 |
Form 3: Morgan Jayne, Director
No securities owned |
| 06 Sep 2022 |
Form 3: Lemerond Nicole, Director
No securities owned |
| 22 Jun 2022 |
Form 3: Sharkey John W., VP, Business Development
Holds 1,860 shares of Common Stock |
| 11 Jan 2022 |
Form 3: McKee Kelly T. Jr., Chief Medical Officer
No securities owned |
| 03 Sep 2020 |
Form 3: Newman Mark J, Chief Scientific Officer
No securities owned |
| 26 Oct 2015 | Form 3: Guirakhoo Farshad, Sr VP, Research & Development |
| 23 Mar 2015 |
Form 3: Chase Randal D, Director
Holds 0 shares of Common Stock |
| 23 Mar 2010 |
Form 3: Dodd David A, Director
Holds 0 shares of Common Stock |
| 19 Mar 2010 |
Form 3: Antebi Steven S., Director
Holds 0 shares of Common Stock |
| 06 Jan 2010 | Form 3: Newman Mark J, VP, Research & Development |
| 22 Aug 2008 |
Form 3: Tsolinas Peter M, Director
Holds 23,486,734 shares of Common Stock |
| 13 Dec 2006 |
Form 3: Mcnally Robert T, Director
Holds 617,742 shares of Common Stock |
| 16 Oct 2006 |
Form 3: Kollintzas Dean G, Director
No securities owned |
| 11 Oct 2006 |
Form 3: Reynolds Mark, CFO and Secretary
No securities owned |
| 11 Oct 2006 |
Form 3: Teal Gary, Director
No securities owned |
| 10 Oct 2006 |
Form 3: Emory University, 10% owner
Holds 233,905,253 shares of Common Stock |
| 10 Oct 2006 |
Form 3: Robinson Harriet L, Chair of Scientific Advisory
Holds 60,426,235 shares of Common Stock |
| 10 Oct 2006 |
Form 3: Murphree Edith, Director
No securities owned |
| 10 Oct 2006 |
Form 3: Hildebrand Donald G, Director
Holds 59,182,847 shares of Common Stock |
| 10 Oct 2006 |
Form 3: Spencer John N Jr, Director
No securities owned |
Loading...